CClinicalTrials.gg
CompletedNCT01862042ASI1Updated Sep 11, 2025

Palliative Care in Spinal Muscular Atrophy (SMA) 1

An interventional study of Follow-up diary and questionnaire in Spinal Muscular Atrophy 1, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 1 Day to 1 Year. Per ClinicalTrials.gov, last updated 2025-09-11.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Not applicable
Ages
1 Day to 1 Year
Sex
All
01

Study summary

The purpose of this study is to evaluate the quality of supportive and palliative care for SMA type 1 patients.

Read the detailed description

Spinal Muscular Atrophy Type I (SMA I) is the most severe form of SMA. It presents in infancy and death occurs by 2 years. There is actually no curative treatment for this pathology. Support and help must be provided from the time of presentation till death and usually this period is quite short, about a couple of months. Variations in medical practice have be seen, depending on the medical experience and sometimes coupled with differences in family resources and values. The aim of the study is to evaluate the needs of the patients and their families, the medical practices, and to describe a cohort of SMA type 1 patients with the natural history of this disease. For this, a follow-up diary will be done, and this diary will be completed by the families and the different practitioners working with the patient. Will be noted in it : physical signs, all therapeutic choices and actions, evaluation of the pain and treatments. A special part of this follow-up diary will be completed by the medical doctors, after the death of the patient, with all the medication used at time of death and the conditions of the death. One year after the death of the patient, a questionnaire will be proposed to the parents of the child by a psychologist. This questionnaire will estimate the benefice of the follow-up diary, and the improvements to give in the diagnostic strategies, recommendations for assessment and monitoring, and therapeutic interventions in SMA type 1.

02

Conditions studied

  • Spinal Muscular Atrophy 1

Keywords

  • Spinal Muscular Atrophy (SMA) type 1
  • Supportive care
  • Palliative care
03

In context

Spinal Muscular Atrophies of Childhood

50 studies on the registry are indexed under Spinal Muscular Atrophies of Childhood; 17 are open to participants now.

This study's enrollment of 39 is above the median of 21 across 40 interventional studies indexed under Spinal Muscular Atrophies of Childhood.

Browse Spinal Muscular Atrophies of Childhood studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 1 Year
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • SMA type 1 under 1 an
  • Genetic confirmation

Exclusion criteria

Exclusion Criteria:

  • No genetic confirmation
  • SMA type 1 over 1 year
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
39 participants (actual)

Study arms

  • Other
    Supportive and Palliative care

    A follow-up diary will be completed by the families and the different practitioners working with the patient. One year after the death of the patient, a questionnaire will be proposed to the parents of the child by a psychologist.

    Other: Follow-up diary and questionnaire

Interventions

  • OtherFollow-up diary and questionnaire

    A follow-up diary will be completed by the families and the different practitioners working with the patient. One year after the death of the patient, a questionnaire will be proposed to the parents of the child by a psychologist.

    Also known as: Supportive and Palliative care

06

What researchers measure

Primary outcomes

  1. %O2

    Quantitative evaluation of care : oxygen therapy and Invasive ventilation

    Time frame: until 2 years

Secondary outcomes

  1. Qualitative evaluation of the practices of care

    Analysis of the semi-structured questionnaire completed remotely by the methods of analysis semi-qualitative. Identification of the principal challenges faced by parents and satisfaction criteria or non-face to the proposed solutions.

    Time frame: until 2 years

  2. Evaluation of nutritional status

    Quantitative evaluation of care : nutritional status and enteral nutrition

    Time frame: until 2 years

  3. Evaluation of orthopedic facilities

    Quantitative evaluation of care : kinesitherapy and orthopedic facility

    Time frame: until 2 years

  4. Evaluation of comfort

    quantitative evaluation of care : criterion for pain analgesics and sedatives care

    Time frame: until 2 years

07

Study locations

1 site
  • Necker Hospital
    Paris, 75015, France
08

References and documents

Publications

  • Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A. 1982 Jan;79(1):175-8. doi: 10.1073/pnas.79.1.175. PubMed 6798568 ↗
  • Kaufmann P, Greiss C, Brown J. Survival in SMA type 1. Neuromuscul Disord. 2009 Jan;19(1):76; author reply 76. doi: 10.1016/j.nmd.2008.10.010. Epub 2008 Dec 12. No abstract available. PubMed 19070490 ↗
  • Roper H, Quinlivan R; Workshop Participants. Implementation of "the consensus statement for the standard of care in spinal muscular atrophy" when applied to infants with severe type 1 SMA in the UK. Arch Dis Child. 2010 Oct;95(10):845-9. doi: 10.1136/adc.2009.166512. Epub 2009 Oct 8. PubMed 19819869 ↗
  • Hully M, Barnerias C, Chabalier D, Le Guen S, Germa V, Deladriere E, Vanhulle C, Cuisset JM, Chabrol B, Cances C, Vuillerot C, Espil C, Mayer M, Nougues MC, Sabouraud P, Lefranc J, Laugel V, Rivier F, Louvier UW, Durigneux J, Napuri S, Sarret C, Renouil M, Masurel A, Viallard ML, Desguerre I. Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports. Front Pediatr. 2020 Feb 18;8:4. doi: 10.3389/fped.2020.00004. eCollection 2020. PubMed 32133329 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01862042
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
May 24, 2013
Start date
Jun 2012
Primary completion
Jun 11, 2018
Completion
Jun 11, 2018
Last update
Sep 11, 2025

Study contacts

Isabelle Desguerre, MD, PhD
study chair · Necker Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion